A Double-Blind, Randomized, Placebo-Controlled Study of the Dopamine D3 Receptor Antagonist ABT-925 in Patients With Acute Schizophrenia
暂无分享,去创建一个
L. Redden | W. Abi-Saab | M. Saltarelli | W. Robieson | Yaqin Wang | A. Goenjian | D. Katz | S. Goss | B. Rendenbach-Mueller | N. Greco